Report Categories
View AllRecent Articles
View All
Novartis Upgrades FullYear Outlook on Strong Operational Momentum
Waystar Holding Corp Faces Market Pressure Amid Growing Concerns Over AI Disruption
Piper Sandler Highlights Potential Pressure on Tractor Supply Amid Weak Pet Spending Trends
SpaceX IPO Buzz Nvidia Earnings and Bezos on AI Key Market Themes
Trump Postpones AI Executive Order Signing Citing Concerns Over Potential Blocker Effect
Shoulder Innovations Inc SI Q1 2026 Earnings NarrowerthanExpected Loss Despite No Reported Revenue
Stran Company Inc Q1 2026 Earnings Profitability Achieved Amid Strategic Initiatives
STT Q1 2026 Earnings EPS Beat Drives Positive Market Response
US Energy Corp USEG Q1 2026 Earnings EPS Misses Estimates Stock Rallies Despite Weak Results
MITK Q1 2026 Earnings EPS Surpasses Estimates on Strong Performance
Sera Prognostics Surges 15 Bullish Momentum Meets Key Resistance at 217
Sky Harbour Group SKYH Gains 17 as Stock Tests Key Resistance Levels
Catheter Precision Inc VTAK Gains 57 as MicroCap Stock Tests Resistance Near 088
Ondas Inc ONDS Surges Over 10 as Bullish Momentum Builds
WWE Clash in Italy Scheduled for May 31 2026 Event Details and Financial Implications
Dow Jones Turns 130 Age Does Not Diminish Market Relevance
Oil Prices Surge as US Military Strikes in Southern Iran Escalate Tensions
Shein Acquires Everlane What the Merger Means for Ethical Fashion and Fast Fashion Consumers
External Links
Petrol Prices Vary Widely Across Indian States Andhra Pradesh Most Expensive Gujarat Cheapest
DigitalOcean DOCN Q1 2026 Earnings Massive EPS Beat of 626 Surprises Market
Primo Brands Corporation PRMB Gains 229 as Stock Approaches Key Resistance
ProKidney Corp PROK Jumps Over 7 as Biotech Stock Tests Resistance at 190
TVACU Holds Steady at 1075 as SPAC Units Trade Flat
Wabash National Corporation WNC Edges Higher Amid Modest Volume Key Levels to Watch
Arbutus Biopharma ABUS Dips 2 Testing Key Support Levels Amid Modest Trading Volume
Waterstone Financial WSBF Faces Pressure as Shares Decline 124
Gain Therapeutics GANX Climbs Higher as Bullish Momentum Builds Near Resistance
Immatics IMTX Surges 5 Breaking Resistance or Facing a Ceiling